Apo-Fluoxetine: The impurities are out of specification and out of trend
Brand(s)
Last updated
Summary
Product
Apo-Fluoxetine
Issue
Health products - Product safety
What to do
Consult your healthcare provider prior to discontinuing use of the affected product, or for any health concerns.
Affected products
Brand |
Product Name |
Market Authorization |
Dosage Form |
Strength |
Lot |
|---|---|---|---|---|---|
Apotex |
Apo-Fluoxetine 20mg |
DIN 02216361 |
Capsule |
Fluoxetine (Fluoxetine hydrochloride) 20mg |
VM4608, VM4612 |
Apotex |
Apo-Fluoxetine 10mg |
DIN 02216353 |
Capsule |
Fluoxetine (Fluoxetine hydrochloride) 10mg |
VM4598 |
Issue
The impurities are out of specification and out of trend in the affected lot.
What you should do
- Verify if your product is affected.
- Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
- Contact the recalling firm if you have any questions about the recall.
- Report any health product related side effects to Health Canada.
- Report any other health product safety complaints to Health Canada.
Additional information
Background
Depth of recall: Retailers
Details
Original published date:
Alert / recall type
Health product recall
Category
Health products - Drugs
Companies
Apotex Inc.
150 Signet Drive
Toronto ON
M9L 1T9
Published by
Health Canada
Audience
General public
Healthcare
Industry
Recall class
Type III
Recall date
Identification number
RA-81883
Get notified
Receive emails about new and updated recall and safety alerts.